Original Research

Published on 27 Mar 2023

Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset

in Thoracic Oncology

Kumar Prabhash
Daniel Shao Weng Tan
Ross A. Soo
Piyada Sitthideatphaiboon
Yuh Min Chen
Pei Jye Voon
Elisna Syahruddin
Sojung Chu
Reto Huggenberger
Byoung-Chul Cho

Frontiers in Oncology

doi 10.3389/fonc.2023.1117348

4,124 views
6 citations

Original Research

Published on 27 Mar 2023

Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database

in Thoracic Oncology

Qike Wang
Lu Zhang
Huahua Li
Linlin Liu
Xu Sun
Huaimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1099117

1,949 views
6 citations

Case Report

Published on 24 Mar 2023

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

in Thoracic Oncology

Pamela Soberanis Pina
Luis Lara-Mejía
Venecia Matias-Cruz
Feliciano Barrón
Andrés F. Cardona
Luis E. Raez
Eduardo Rios-Garcia
Oscar Arrieta

Frontiers in Oncology

doi 10.3389/fonc.2023.1108124

3,163 views
3 citations

Original Research

Published on 24 Mar 2023

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

in Thoracic Oncology

Saud Alhusaini
Tyler A. Lanman
Ryan B. Ko
Kate E. Therkelsen
Rie Von Eyben
Maximilian Diehn
Scott G. Soltys
Erqi L. Pollom
Alexander Chin
Lucas Vitzthum

Frontiers in Oncology

doi 10.3389/fonc.2023.1139940

2,159 views
1 citation

Original Research

Published on 23 Mar 2023

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy

in Thoracic Oncology

Qing Wu
Mengyuan Chen
Fang Peng
Qun Zhang
Yue Kong
Yong Bao
Yujin Xu
Xiao Hu
Ming Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1118371

1,854 views
5 citations

Original Research

Published on 23 Mar 2023

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC

in Thoracic Oncology

Hongxiang Huang
Peiyuan Zhong
Xie Zhu
Silv Fu
Siling Li
Sujuan Peng
Yangyang Liu
Zhihui Lu
Li Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1137224

1,465 views
8 citations

Original Research

Published on 23 Mar 2023

Neoadjuvant radiotherapy plus single-incision thoracoscopic surgery in the treatment of type B3 thymomas

in Thoracic Oncology

Wenshan Li
Yimin Wu
Lijian Huang
Ying Chai

Frontiers in Oncology

doi 10.3389/fonc.2023.1094974

1,233 views

Brief Research Report

Published on 21 Mar 2023

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis

in Thoracic Oncology

Samuel A. Kareff
Kunal Gawri
Khadeja Khan
Deukwoo Kwon
Estelamari Rodriguez
Gilberto de Lima Lopes
Richa Dawar

Frontiers in Oncology

doi 10.3389/fonc.2023.1012783

4,008 views
2 citations

Original Research

Published on 20 Mar 2023

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis

in Thoracic Oncology

Li-Hua Zhu
Xing-Wen Fan
Lu Sun
Ting-ting Ni
Ya-qi Li
Chao-Yang Wu
Kai-Liang Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1093084

1,545 views
2 citations

Original Research

Published on 20 Mar 2023

CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma

in Thoracic Oncology

Jingting Wang
Feiyang Zhong
Feng Xiao
Xinyang Dong
Yun Long
Tian Gan
Ting Li
Meiyan Liao

Frontiers in Oncology

doi 10.3389/fonc.2023.1157891

2,187 views
2 citations

Original Research

Published on 20 Mar 2023

Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

in Thoracic Oncology

Yang Wang
Shilei Qin
Yuepei Liang
Ling Yan
Min Zheng
Yanwu Zeng
Leilei Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1119575

1,590 views
1 citation

Original Research

Published on 17 Mar 2023

Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma

in Thoracic Oncology

Zhe-Rong Zheng
Hsiu-Ying Ku
Kun-Chieh Chen
Chun-Ju Chiang
Chih-Liang Wang
Chih-Yi Chen
Chun-Ming Tsai
Ming-Shyan Huang
Chong-Jen Yu
Jin-Shing Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1063695

1,999 views
1 citation

Systematic Review

Published on 16 Mar 2023

Comparison of the second-line treatments for patients with small cell lung cancer sensitive to previous platinum-based chemotherapy: A systematic review and Bayesian network analysis

in Thoracic Oncology

Hekai Shi
Nuojin Guo
Zeming Zhao
Ligang Liu
Tianyi Ni
Jinye Zhang
Yingjie Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1154685

3,210 views
4 citations

Case Report

Published on 16 Mar 2023

Case report: The stroma-rich variant of Castleman’s disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node

in Thoracic Oncology

Xiaoxin Shi
Mengying Liao
Xiaomin Yin
Yaoli Chen
Chuqiang Huang
Weihua Yin
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1008587

1,740 views
3 citations

Case Report

Published on 16 Mar 2023

Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report

in Thoracic Oncology

Zhifeng Ye
Junhua Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1082115

2,088 views
1 citation

Original Research

Published on 15 Mar 2023

Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region

in Thoracic Oncology

Yunjiao Wu
Jing Yang
Xinyi Qiao
Yingjie Li
Rui Zhao
Tie Lin
Xiaoli Li
Meng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1041140

1,969 views
1 citation

Navigation group

Articles

Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset

Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC

Neoadjuvant radiotherapy plus single-incision thoracoscopic surgery in the treatment of type B3 thymomas

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis

CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma

Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma

Comparison of the second-line treatments for patients with small cell lung cancer sensitive to previous platinum-based chemotherapy: A systematic review and Bayesian network analysis

Case report: The stroma-rich variant of Castleman’s disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node

Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report

Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region